Clinical consequences of asbestos-related diffuse pleural thickening: A review

Journal of Occupational Medicine and Toxicology

Volumn 3, Issue 1, 2008, Pages

  Miles, Susan E ^a,b   Sandrini, Alessandra ^a,b   Johnson, Anthony R ^a   Yates, Deborah H ^a,b  

^a Dust Diseases Board Research and Education Unit   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 52649114269     PISSN: None     EISSN: 17456673     Source Type: Journal    
DOI: 10.1186/1745-6673-3-20     Document Type: Review

References (67)

1. Projected mesothelioma incidence in men in New South Wales. M Clements G Berry J Shi S Ware D Yates A Johnson, Occup Environ Med 2007 64 747 52 10.1136/oem.2006.031823 17449562
2. Diffuse pleural thickening in an asbestos-exposed population: prevalence and causes. TC McLoud BO Woods CB Carrington GR Epler EA Gaensler, AJR Am J Roentgenol 1985 144 1 9 18 3871154
3. Asbestos and the pleura: a review. DW Cugell DW Kamp, Chest 2004 125 1103 17 10.1378/chest.125.3.1103 15006974
4. Report on effects of asbestos on the lungs and dust suppression in the asbestos industry. ERA Merewether CW Price, London 1930
5. The occurrence of pleural calcification among asbestos insulation workers. IJ Selikoff, Ann N Y Acad Sci 1965 132 351 67 10.1111/j.1749-6632.1965. tb41116.x 5219560
6. Asbestos-related bilateral diffuse pleural thickening: natural history of radiographic and lung function abnormalities. DH Yates K Browne PN Stidolph E Neville, Am J Respir Crit Care Med 1996 153 301 6 8542134
7. New developments in asbestos-related pleural disease. RM Rudd, Thorax 1996 51 210 6 8711661
8. A case of hypercapnic respiratory failure. D Baram A Degene M Amin T Bilfinger G Smaldone, Chest 2004 126 1994 9 10.1378/chest.126.6.1994 15596704
9. The relationship between respiratory impairment and asbestos-related pleural abnormality in an active work force. J Bourbeau P Ernst J Chrome B Armstrong MR Becklake, Am Rev Respir Dis 1990 142 837 42 2221591
10. The surveillance of Australian Workplace-based Respiratory Events (SABRE) scheme in three states [abstract]. A Johnson K Hannaford-Turner A Little D Yates M Sim D Elder M Abramson, Respirology 2007 12 Suppl 1 A30 A78
11. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med 2004 170 691 715 10.1164/rccm.200310-1436ST 15355871
12. Pleural calcification, pleural mesotheliomas, and bronchial cancers caused by tremolite dust. S Yazicioglu R Ilcayto K Balci BS Sayli B Yorulmaz, Thorax 1980 35 564 9 7444823
13. Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. I. Review of exposure and epidemiological data. S Luo X Liu S Mu SP Tsai CP Wen, Occup Environ Med 2003 60 35 41 discussion 41-2. 12499455 10.1136/oem.60.1.35
14. Screening for asbestos-induced diseases in Finland. K Koskinen JP Rinne A Zitting A Tossavainen J Kivekas K Reijula P Roto MS Huuskonen, Am J Ind Med 1996 30 241 51 10.1002/(SICI)1097-0274(199609)30:3<241::AID-AJIM1>3.0. CO;2-1 8876791
15. Environmental pleural plaques in an asbestos exposed population of northeast Corsica. F Rey C Boutin J Steinbauer JR Viallat P Alessandroni P Jutisz D Di Giambattista MA Billon-Galland P Hereng P Dumortier, Eur Respir J 1993 6 978 82 8396536
16. Pleural plaques and exposure to mineral fibres in a male urban necropsy population. A Karjalainen PJ Karhunen K Lalu A Penttila E Vanhala P Kyyronen A Tossavainen, Occup Environ Med 1994 51 456 60 8044244
17. New developments in asbestos-induced pleural disease. DA Schwartz, Chest 1991 99 191 8 10.1378/chest.99.1.191 1984952
18. Asbestos-related benign pleural disease. C Peacock SJ Copley DM Hansell, Clin Radiol 2000 55 422 32 10.1053/crad.2000.0450 10873686
19. Fibre distribution in the lungs and pleura of subjects with asbestos related diffuse pleural fibrosis. AR Gibbs M Stephens DM Griffiths BJ Blight FD Pooley, Br J Ind Med 1991 48 762 70 1659443
20. Asbestos retention in human respiratory tissues: comparative measurements in lung parenchyma and in parietal pleura. P Sebastien X Janson A Gaudichet A Hirsch J Bignon, IARC Sci Publ 1980 237 46 7239642
21. Relationship of mortality to measures of environmental asbestos pollution in an asbestos textile factory. J Peto R Doll C Hermon W Binns R Clayton T Goffe, Ann Occup Hyg 1985 29 305 55 10.1093/annhyg/29.3.305 4073702
22. Diffuse pleural fibrosis-an unreliable indicator of heavy asbestos exposure? KA Smith LJ Sykes CR McGavin, Scand J Work Environ Health 2003 29 60 3 12630437
23. Determination of mineral fibre in human lung tissue by light microscopy and transmission electron microscopy. AJ Rogers, Ann Occup Hyg 1984 28 1 12 10.1093/annhyg/28.1.1 6326648
24. Asbestos-induced pleural disease. SL Nishimura VC Broaddus, Clin Chest Med 1998 19 311 29 10.1016/S0272-5231(05)70079-4 9646983
25. AR Brody, Asbestos New York: Elsevier Science 1997
26. The pathogenesis of pleural plaques and pulmonary asbestosis: possibilities and impossibilities. G Hillerdal, Eur J Respir Dis 1980 61 129 38 7002573
27. Cellular and molecular basis of the asbestos-related diseases. WN Rom WD Travis AR Brody, Am Rev Respir Dis 1991 143 408 22 1990961
28. Characterization of the lower respiratory tract inflammation of nonsmoking individuals with interstitial lung disease associated with chronic inhalation of inorganic dusts. WN Rom PB Bitterman SI Rennard A Cantin RG Crystal, Am Rev Respir Dis 1987 136 1429 34 2825569
29. A current hypothesis of the lymphatic transport of inspired dust to the parietal pleura. E Taskinen K Ahlamn M Wukeri, Chest 1973 64 193 6 10.1378/chest.64.2.193 4725075
30. Pathogenesis of pleural fibrosis. SE Mutsaers CM Prele AR Brody S Idell, Respirology 2004 9 428 40 10.1111/j.1440-1843.2004.00633.x 15612953
31. Causes and management of pleural fibrosis. JT Huggins SA Sahn, Respirology 2004 9 441 7 10.1111/j.1440-1843.2004.00630.x 15612954
32. A single intrapleural injection of transforming growth factor-beta(2) produces an excellent pleurodesis in rabbits. RW Light DS Cheng YC Lee J Rogers J Davidson KB Lane, Am J Respir Crit Care Med 2000 162 98 104 10903227
33. Transforming growth factor-beta2 induces pleurodesis significantly faster than talc. YC Gary Lee LR Teixeira CJ Devin MA Vaz FS Vargas PJ Thompson KB Lane RW Light, Am J Respir Crit Care Med 2001 163 640 4 11254517
34. The molecular basis of asbestos induced lung injury. DW Kamp SA Weitzman, Thorax 1999 54 638 52 10377212
35. Asbestos inhalation induces reactive nitrogen species and nitrotyrosine formation in the lungs and pleura of the rat. S Tanaka N Choe DR Hemenway S Zhu S Matalon E Kagan, J Clin Invest 1998 102 445 54 9664087 10.1172/JCI3169
36. Pathogenesis of pleural plaques. Relationship of early cellular response and pathology. SA Sahn VB Antony, Am Rev Respir Dis 1984 130 884 7 6497167
37. Benign asbestos pleural effusion: 73 exudates in 60 patients. G Hillerdal M Ozesmi, Eur J Respir Dis 1987 71 113 21 3622660
38. Prevalence and incidence of benign asbestos pleural effusion in a working population. GR Epler TC McLoud EA Gaensler, Jama 1982 247 617 22 10.1001/jama.247.5.617 7054563
39. Symptomatic benign pleural effusions among asbestos insulation workers: residual radiographic abnormalities. R Lilis Y Lerman IJ Selikoff, Br J Ind Med 1988 45 443 9 3260799
40. Malignant mesothelioma 1982: review of 4710 published cases. G Hillerdal, Br J Dis Chest 1983 77 321 43 6357260
41. Ventilatory failure due to asbestos pleurisy. A Miller AS Teirstein IJ Selikoff, Am J Med 1983 75 911 9 10.1016/0002-9343(83)90863-X 6650544
42. Chest pain in asbestos-exposed individuals with benign pleural and parenchymal disease. S Mukherjee N de Klerk LJ Palmer NJ Olsen SC Pang A William Musk, Am J Respir Crit Care Med 2000 162 1807 11 11069817
43. Radiographic abnormalities and mortality in subjects with exposure to crocidolite. NH de Klerk AW Musk WO Cookson JJ Glancy MS Hobbs, Br J Ind Med 1993 50 902 6 8217849
44. Association between pleural plaques and coronary heart disease. O Korhola A Hiltunen A Karjalainen R Martikainen H Riihimaki, Scand J Work Environ Health 2001 27 154 5 11409599
45. Functional consequences of pleural disease evaluated with chest radiography and CT. SJ Copley AU Wells MB Rubens F Chabat RE Sheehan AW Musk DM Hansell, Radiology 2001 220 237 43 11426004
46. Effect of asbestos-related pleural fibrosis on excursion of the lower chest wall and diaphragm. B Singh PR Eastwood KE Finucane JA Panizza AW Musk, Am J Respir Crit Care Med 1999 160 1507 15 10556113
47. [International Labor Office International Classification of Radiographs of Pneumoconioses.]. Geneva, Switzerland: International Labour Organization 2003
48. High-resolution CT of benign asbestos-related diseases: clinical and radiographic correlation. DR Aberle G Gamsu CS Ray, AJR Am J Roentgenol 1988 151 5 883 891 3263018
49. Conventional and high resolution computed tomography in the diagnosis of asbestos-related diseases. DA Lynch G Gamsu DR Aberle, Radiographics 1989 9 523 51 2727359
50. Computed tomogrpahy of asbestos-related pleural abnormalities. M Tiitola L Kivisaari A Zitting MS Huuskonen S Kaleva A Tossavainen T Vehmas, Int Arch Occup Environ Health 2002 75 224 28 10.1007/s00420-001-0297-x 11981655
51. Asbestos-related pleuropulmonary diseases: evaluation with low-dose four-detector row spiral CT. M Remy-Jardin A Sobaszek A Duhamel I Mastora C Zanetti J Remy, Radiology 2004 233 182 90 10.1148/radiol.2331031133 15333769
52. Pleural and parenchymal fibrosis mainly affecting the upper lung lobes in persons exposed to asbestos. G Hillerdal, Respir Med 1990 84 129 34 10.1016/S0954-6111(08)80015-7 2371434
53. MRI and CT in the differential diagnosis of pleural disease. J Hierholzer L Luo RC Bittner C Stroszczynski RJ Schroder N Schoenfeld P Dorow R Loddenkemper A Grassot, Chest 2000 118 604 9 10.1378/chest.118.3.604 10988179
54. Magnetic resonance imaging in distinguishing malignant from benign pleural disease. L Luo J Hierholzer RC Bittner J Chen L Huang, Chin Med J (Engl) 2001 114 645 9 11780445
55. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. F Benard D Sterman RJ Smith LR Kaiser SM Albelda A Alavi, Chest 1998 114 713 22 10.1378/chest.114.3.713 9743156
56. Asbestos-related pleural disease: value of dedicated magnetic resonance imaging techniques. MA Weber M Bock C Plathow K Wasser C Fink I Zuna A Schmahl I Berger HU Kauczor SO Schoenberg, Invest Radiol 2004 39 554 64 10.1097/01.rli.0000131888.39636.c5 15308938
57. The role of imaging in malignant pleural mesothelioma. EM Marom JJ Erasmus HI Pass EF Patz Jr, Semin Oncol 2002 29 26 35 10.1053/sonc.2002.30228 11836666
58. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. RM Flores T Akhurst M Gonen SM Larson VW Rusch, J Thorac Cardiovasc Surg 2003 126 11 6 10.1016/S0022-5223(03)00207-1 12878934
59. Positron emission tomography predicts survival in malignant pleural mesothelioma. RM Flores T Akhurst M Gonen M Zakowski J Dycoco SM Larson VW Rusch, J Thorac Cardiovasc Surg 2006 132 763 8 10.1016/j.jtcvs.2006.03.068 17000285
60. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications. JJ Erasmus MT Truong WR Smythe RF Munden EM Marom DC Rice AA Vaporciyan GL Walsh BS Sabloff LD Broemeling CW Stevens KM Pisters DA Podoloff HA Macapinlac, J Thorac Cardiovasc Surg 2005 129 1364 70 10.1016/j.jtcvs.2004. 10.034 15942579
61. Asbestosis, pleural plaques and diffuse pleural thickening: three distinct benign responses to asbestos exposure. PA Gevenois V de Maertelaer A Madani C Winant G Sergent P De Vuyst, Eur Respir J 1998 11 1021 7 10.1183/09031936.98.11051021 9648950
62. The folded lung. A Blesovsky, Br J Dis Chest 1966 60 19 22 10.1016/S0007-0971(66)80017-7 5920504
63. Relationship between pleural effusion and pericardial involvement after myocardial revascularization. FS Vargas A Cukier W Hueb LR Teixeira RW Light, Chest 1994 105 1748 52 10.1378/chest.105.6.1748 8205871
64. The pleural manifestations of asbestos exposure. L Rosenstock LD Hudson, Occup Med 1987 2 383 407 3303386
65. CT in differential diagnosis of diffuse pleural disease. AN Leung NL Muller RR Miller, Am J Roentgenol 1990 154 487 92 2106209
66. Ventilatory insufficiency due to asbestos-related diffuse pleural fibrosis successfully treated with non invasive home mechanical ventilation. X Munoz A Roger E Pallisa S Marti J Ferrer, Respiration 2001 68 533 6 10.1159/000050564 11694819
67. Respiratory function changes after asbestos pleurisy. PH Wright A Hanson L Kreel LH Capel, Thorax 1980 35 31 6 7361282